株式会社グローバルインフォメーション
TEL: 044-952-0102
市場調査レポート

医薬品有効成分の世界市場 - 市場規模、シェア、展望および機会分析(2017年~2025年)

Active Pharmaceutical Ingredients Market - Global Industry Insights, Trends, Outlook, and Opportunity Analysis, 2017-2025

発行 Coherent Market Insights 商品コード 833141
出版日 ページ情報 英文 178 Pages
納期: 2-3営業日
価格
本日の銀行送金レート: 1USD=110.59円で換算しております。
Back to Top
医薬品有効成分の世界市場 - 市場規模、シェア、展望および機会分析(2017年~2025年) Active Pharmaceutical Ingredients Market - Global Industry Insights, Trends, Outlook, and Opportunity Analysis, 2017-2025
出版日: 2019年04月29日 ページ情報: 英文 178 Pages
概要

医薬品有効成分(API)は医薬製剤の製造に使用される活性成分であり、そして身体に対して薬理学的および治療的効果を有します。 APIは生の形では使用できないので、それらは薬理学的および治療的に不活性であるがその安定性および活性を増強する適切な賦形剤と組み合わされます。

当レポートでは、世界の医薬品有効成分市場を調査し、市場の概要、タイプ、地域別の市場動向、市場規模の推移と予測、市場促進・阻害要因ならびに市場機会の分析、競合情勢、主要企業のプロファイルなど包括的な情報を提供しています。

目次

第1章 調査目的と前提条件

  • 調査目的
  • 前提条件
  • 略語

第2章 市場範囲

  • レポートについて
    • 市場の定義と範囲
  • エグゼクティブサマリー
    • API別市場
    • 合成タイプ別市場
    • アプリケーション別市場
    • 地域別市場
  • Coherentの市場機会マップ(COM)

第3章 市場のダイナミクス、規制、および動向分析

  • 市場ダイナミクス
    • 成長要因
    • 阻害要因
    • 市場機会
  • インパクト解析
  • 市場動向
  • PEST分析
  • M&A
  • API特許の有効期限
  • 規制シナリオ
  • パイプライン分析

第4章 API別市場、2018年~2026年(10億米ドル)

  • イントロダクション
  • 先発/革新的医薬品
  • ジェネリック医薬品

第5章 合成タイプ別市場、2018年~2026年(10億米ドル)

  • イントロダクション
  • 合成
  • バイオテック

第6章 アプリケーション別市場、2018年~2026年(10億米ドル)

  • イントロダクション
  • 糖尿病
  • 腫瘍学
  • 心血管
  • CNS
  • 鎮痛薬
  • その他

第7章 地域別市場、2018年~2026年(10億米ドル)

  • イントロダクション
  • 北米
  • 中南米
  • 欧州
  • アジア太平洋地域
  • 中東
  • アフリカ

第8章 競合情勢

  • ヒートマップ解析
  • 市場シェア分析
  • 企業プロファイル
    • Teva Pharmaceutical Industries Ltd.
      • API ポートフォリオ
    • Pfizer, Inc.
    • BASF SE
    • Dr. Reddy's Laboratories Ltd
    • Novartis AG
    • Mylan N.V.
    • Sanofi S.A.
    • Lonza
  • アナリストの意見

第9章 セクション

  • 参考文献
  • 調査方法
  • Coherent Market Insightsについて
目次

Active Pharmaceutical Ingredients (API) are active constituents used in the manufacturing of pharmaceutical formulations and have pharmacological and therapeutic effects on the body. Since APIs cannot be used in the raw form, they are combined with the suitable excipients, which are pharmacologically and therapeutically inactive but enhance its stability and activities.

Market Dynamics

Increasing prevalence of chronic diseases, geographical expansion of active pharmaceutical ingredient manufacturers in Asia, and increasing investment in research and development by manufacturers are some of the major factors that are expected to drive the market growth. Furthermore, increasing production of generic drugs is in turn driving growth of global active pharmaceutical ingredients market. For instance, according to the Indian Brand Equity Foundation (IBEF), in 2018, India was the largest producer of generic medicines, which supplied 50% of vaccines and 40% of drugs to the U.S. and 25% of drugs to the U.K. However, unfavorable drug price control policies across various countries is expected to negatively affect growth of the market.

Key features of the study:

  • This report provides in-depth analysis of the active pharmaceutical ingredients market and provides market size (US$ Bn) and Compound Annual Growth Rate (CAGR %) for the forecast period (2018 - 2026), considering 2017 as the base year
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
  • It profiles key players in the global active pharmaceutical ingredients market based on the following parameters - company overview, financial performance, product portfolio, market presence, distribution strategies, key developments, strategies, and future plans
  • Key companies covered as a part of this study include Teva Pharmaceutical Industries Ltd., Pfizer, Inc., BASF SE, Dr. Reddy's Laboratories Ltd., Novartis AG, Mylan N.V., Sanofi S.A., and Lonza
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, technology up-gradation, market expansion, and marketing tactics
  • The global active pharmaceutical ingredients market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the active pharmaceutical ingredients market

Detailed Segmentation:

  • Global Active Pharmaceutical Ingredients Market, By API:
    • Branded/ Innovative
    • Generic
  • Global Active Pharmaceutical Ingredients Market, By Type of Synthesis:
    • Synthetic
    • Biotech
  • Global Active Pharmaceutical Ingredients Market, By Application:
    • Diabetes
    • Oncology
    • Cardiovascular
    • CNS
    • Analgesics
    • Others
  • Global Active Pharmaceutical Ingredients Market, By Region:
    • North America
      • By API:
      • Branded/ Innovative
      • Generic
      • By Type of Synthesis:
      • Synthetic
      • Biotech
      • By Application:
      • Diabetes
      • Oncology
      • Cardiovascular
      • CNS
      • Analgesics
      • Others
      • By Country:
      • U.S.
      • Canada
    • Latin America
      • By API:
      • Branded/ Innovative
      • Generic
      • By Type of Synthesis:
      • Synthetic
      • Biotech
      • By Application:
      • Diabetes
      • Oncology
      • Cardiovascular
      • CNS
      • Analgesics
      • Others
      • By Country:
      • Brazil
      • Mexico
      • Argentina
      • Rest of Latin America
    • Europe
      • By API:
      • Branded/ Innovative
      • Generic
      • By Type of Synthesis:
      • Synthetic
      • Biotech
      • By Application:
      • Diabetes
      • Oncology
      • Cardiovascular
      • CNS
      • Analgesics
      • Others
      • By Country:
      • Germany
      • U.K.
      • France
      • Italy
      • Spain
      • Russia
      • Rest of Europe
    • Asia Pacific
      • By API:
      • Branded/ Innovative
      • Generic
      • By Type of Synthesis:
      • Synthetic
      • Biotech
      • By Application:
      • Diabetes
      • Oncology
      • Cardiovascular
      • CNS
      • Analgesics
      • Others
      • By Country:
      • China
      • India
      • Japan
      • Australia
      • South Korea
      • ASEAN
      • Rest of Asia Pacific
    • Middle East
      • By API:
      • Branded/ Innovative
      • Generic
      • By Type of Synthesis:
      • Synthetic
      • Biotech
      • By Application:
      • Diabetes
      • Oncology
      • Cardiovascular
      • CNS
      • Analgesics
      • Others
      • By Country:
      • GCC
      • Israel
      • Rest of Middle East
    • Africa
      • By API:
      • Branded/ Innovative
      • Generic
      • By Type of Synthesis:
      • Synthetic
      • Biotech
      • By Application:
      • Diabetes
      • Oncology
      • Cardiovascular
      • CNS
      • Analgesics
      • Others
      • By Country:
      • South Africa
      • Central Africa
      • North Africa
  • Company Profiles
    • Teva Pharmaceutical Industries Ltd.*
      • Company Overview
      • Material Portfolio
      • Financial Performance
      • Key Highlights
      • Market Strategies
    • Pfizer, Inc.
    • BASF SE
    • Dr. Reddy's Laboratories Ltd.
    • Novartis AG
    • Mylan N.V.
    • Sanofi S.A.
    • Lonza

"*" marked represents similar segmentation in other categories in the respective section.

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Snippet, By API
    • Market Snippet, By Type of Synthesis
    • Market Snippet, By Application
    • Market Snippet, By Region
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Drivers
    • Restraints
    • Market Opportunities
  • Impact Analysis
  • Market Trends
  • PEST Analysis
  • Mergers and Acquisitions
  • API Patent Expiration
  • Regulatory Scenario
  • Pipeline Analysis

4. Global Active Pharmaceutical Ingredients Market, By API, 2018 - 2026, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2016 and 2026 (%)
    • Y-o-Y Growth Analysis, 2017 - 2026
    • Segment Trends
  • Branded/ Innovative
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026, (US$ Bn)
  • Generic
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026, (US$ Bn)

5. Global Active Pharmaceutical Ingredients Market, By Type of Synthesis, 2018 - 2026, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2016 and 2026 (%)
    • Y-o-Y Growth Analysis, 2017 - 2026
    • Segment Trends
  • Synthetic
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026, (US$ Bn)
  • Biotech
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026, (US$ Bn)

6. Global Active Pharmaceutical Ingredients Market, By Application, 2018 - 2026, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2016 and 2026 (%)
    • Y-o-Y Growth Analysis, 2017 - 2026
    • Segment Trends
  • Diabetes
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026, (US$ Bn)
  • Oncology
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026, (US$ Bn)
  • Cardiovascular
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026, (US$ Bn)
  • CNS
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026, (US$ Bn)
  • Analgesics
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026, (US$ Bn)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026, (US$ Bn)

7. Global Active Pharmaceutical Ingredients Market, By Region, 2018 - 2026, (US$ Bn)

  • Introduction
    • Market Share Analysis, By Region, 2016 and 2026 (%)
    • Y-o-Y Growth Analysis, For Regions, 2017-2026
  • North America
    • Market Size and Forecast, By API, 2016 - 2026, (US$ Bn)
    • Market Size and Forecast, By Type of Synthesis, 2016 - 2026, (US$ Bn)
    • Market Size and Forecast, By Application, 2016 - 2026, (US$ Bn)
    • Market Size and Forecast, By Country, 2016 - 2026, (US$ Bn)
    • U.S.
    • Canada
  • Latin America
    • Market Size and Forecast, By API, 2016 - 2026, (US$ Bn)
    • Market Size and Forecast, By Type of Synthesis, 2016 - 2026, (US$ Bn)
    • Market Size and Forecast, By Application, 2016 - 2026, (US$ Bn)
    • Market Size and Forecast, By Country, 2016 - 2026, (US$ Bn)
    • Brazil
    • Mexico
    • Argentina
    • Rest of Latin America
  • Europe
    • Market Size and Forecast, By API, 2016 - 2026, (US$ Bn)
    • Market Size and Forecast, By Type of Synthesis, 2016 - 2026, (US$ Bn)
    • Market Size and Forecast, By Application, 2016 - 2026, (US$ Bn)
    • Market Size and Forecast, By Country, 2016 - 2026, (US$ Bn)
    • Germany
    • U.K.
    • France
    • Italy
    • Spain
    • Russia
    • Rest of Europe
  • Asia Pacific
    • Market Size and Forecast, By API, 2016 - 2026, (US$ Bn)
    • Market Size and Forecast, By Type of Synthesis, 2016 - 2026, (US$ Bn)
    • Market Size and Forecast, By Application, 2016 - 2026, (US$ Bn)
    • Market Size and Forecast, By Country, 2016 - 2026, (US$ Bn)
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
  • Middle East
    • Market Size and Forecast, By API, 2016 - 2026, (US$ Bn)
    • Market Size and Forecast, By Type of Synthesis, 2016 - 2026, (US$ Bn)
    • Market Size and Forecast, By Application, 2016 - 2026, (US$ Bn)
    • Market Size and Forecast, By Country, 2016 - 2026, (US$ Bn)
    • GCC
    • Israel
    • Rest of Middle East
  • Africa
    • Market Size and Forecast, By API, 2016 - 2026, (US$ Bn)
    • Market Size and Forecast, By Type of Synthesis, 2016 - 2026, (US$ Bn)
    • Market Size and Forecast, By Application, 2016 - 2026, (US$ Bn)
    • Market Size and Forecast, By Country/Region, 2016 - 2026, (US$ Bn)
    • South Africa
    • Central Africa
    • North Africa

8. Competitive Landscape

  • Heat Map Analysis
  • Market Share Analysis
  • Company Profiles
    • Teva Pharmaceutical Industries Ltd.*
    • Company Overview
    • API Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Pfizer, Inc.
    • Company Overview
    • API Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • BASF SE
    • Company Overview
    • API Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Dr. Reddy's Laboratories Ltd
    • Company Overview
    • API Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Novartis AG
    • Company Overview
    • API Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Mylan N.V.
    • Company Overview
    • API Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Sanofi S.A.
    • Company Overview
    • API Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Lonza
    • Company Overview
    • API Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
  • Analyst Views

9. Section

  • References
  • Research Methodology
  • About Us and Sales Contact
Back to Top